Nvidia has launched the NVIDIA BioNeMo Agent Toolkit, an AI suite designed to automate complex scientific workflows in biotech and pharma. This toolkit leverages Nvidia’s microservices and tools to accelerate tasks such as protein structure prediction and drug candidate identification, significantly speeding up research and development processes for partners like the University of Washington's Institute for Protein Design.
Read the full article at Genetic Engineering News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.





